Visit the AHRP blog:
http://ahrp.blogspot.com
Top News arrow Research Integrity
New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost PDF Print E-mail
Friday, 01 December 2006
U.S. State Attorneys General should investigate the fraudulent marketing of the atypical neuroleptic drugs-and FDA's role in helping conceal the truth.
Read more...
 
Negative Research Results--Mostly Concealed in Journals_SharonBegley, WSJ PDF Print E-mail
Sunday, 26 November 2006
"Why are scientists coy about publishing negative data?
Read more...
 
Antipsychotics, Newer Isn't BetterDrug_Washington Post front page PDF Print E-mail
Tuesday, 03 October 2006
“a study published yesterday overturns conventional wisdom about antipsychotic drugs, which cost the United States $10 billion a year.”
Read more...
 
Pediatric Cardiologist Explains: The crucial health stat you've never heard of_Slate PDF Print E-mail
Saturday, 30 September 2006
Dr. Sanghavi provides us with a statistical reality-check by which to gauge for ourselves whether or not we should--or need not--take a  octor's advice about starting a medical treatment for a speculated risk--rather than evidence of illness.
Read more...
 
Marketing Suicide by Misapplying Population Trends_No Competing Interests? PDF Print E-mail
Friday, 25 August 2006
Suicide rates fluctuate. Like the stock market their rise and fall is not due to a single decisive cause, but rather to a confluence of complex factors.
Read more...
 
<< Start < Prev 1 2 Next > End >>

Results 10 - 15 of 15
(C) 2008 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]